首页/数据集/Phase 2 and 3 trials in Alzheimer’s drug development by region 2025

Phase 2 and 3 trials in Alzheimer’s drug development by region 2025

Statista2026-04-11 收录

数据链接：

https://www.statista.com/statistics/1173719/location-sites-for-phase-2-and-3-trials-for-alzheimer-disease-by-location/数据链接链接失效反馈

官方服务：

资源简介：

Share of phase II and III trials targeting the Alzheimer’s disease as of 2025, by location

应用场景：

阿尔茨海默病药物

局部药物递送

There are many steps involved in the molecular cascade that causes the clinical symptoms of Alzheimer’s disease, and identifying which step to try to block is complex. Recently, a critical step in the

Monash University Figshare2026-02-11 更新80

Additional file 1 of Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease

阿尔茨海默病药物

神经细胞模型

Additional file 1.

DataCite Commons2024-09-11 更新80

The transition midpoint temperature (Tm) calculated from DSC curves of Aβ42 in absence and presence of doliroside A.

蛋白质热稳定性分析

阿尔茨海默病药物

The transition midpoint temperature (Tm) calculated from DSC curves of Aβ42 in absence and presence of doliroside A.

Figshare2017-10-31 更新40

Systematic Review: Representativeness of Participants in RCTs of Acetylcholinesterase Inhibitors

阿尔茨海默病药物

临床试验代表性评估

Objective To determine whether there are differences in age and sex distribution and presence of comorbidities between participants included in randomized controlled trials of acetylcholinesterase inh

NIAID Data Ecosystem80

Spectroelectrochemical studies of TDMQ20: a potential drug against Alzheimer’s Disease

药物电化学分析

阿尔茨海默病药物

Celem pracy było zbadanie właściwości elektrochemicznych i spektro-elektrochemicznych potencjalnego leku przeciw chorobie Alzheimera.

DataCite Commons2024-11-04 更新70